null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Lacnotuzumab Biosimilar (Anti-M-CSF) Antibody (HDBS0091)

SKU HDBS0091
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein M-CSF
Reactivity Human
Host Species Humanized
Isotype IgG1
€431
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Lacnotuzumab (Anti-M-CSF) Biosimilar Antibody (HDBS0091)

The Lacnotuzumab Biosimilar Anti-M-CSF Antibody available at Assay Genie is a cutting-edge product designed for research involving the M-CSF protein, a key regulator of the growth and differentiation of monocytes and macrophages. This antibody, derived from a biosimilar source, is highly specific and sensitive in detecting M-CSF in human samples, making it an invaluable tool for studying immune responses and inflammatory processes.The M-CSF protein plays a crucial role in immune system function by promoting the development and activation of macrophages, which are essential for immune defense and tissue repair. Dysregulation of M-CSF signaling has been implicated in various diseases, including cancer, arthritis, and osteoporosis, making it a promising target for therapeutic interventions.

Researchers can utilize this antibody to study the expression and function of M-CSF in different cell types, offering insights into disease mechanisms and potential treatment strategies.With its high reactivity and specificity, the Lacnotuzumab Biosimilar Anti-M-CSF Antibody is a valuable tool for investigating the role of M-CSF in health and disease. Its application in various research settings, from immunology to oncology, makes it a versatile reagent for advancing our understanding of immune regulation and developing novel therapies.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose